| Document |
Document Title |
|
WO/1996/009297A1 |
Novel compounds, compositions and methods effective for the prevention and treatment of mast-cell mediated inflammatory disorders are described. The compounds, compositions and methods are effective for the prevention and treatment of in...
|
|
WO/1996/009276A1 |
The present invention relates to cationic compounds and their application in detergent compositions. The compounds have the dual benefits of surfactancy and of suds suppression.
|
|
WO/1996/006068A1 |
A benzene compound represented by general formula (I) (wherein each symbol is as defined in the specification), an optical isomer or salt thereof, a medicinal composition containing the same, and an immunosuppressant containing the same ...
|
|
WO/1996/003369A1 |
The present invention relates to novel antioxidant compounds to reduce the physical or chemical degradation or discoloration of surfaces, especially the fading of a variety of surfaces from sunlight, wherein the antioxidant compound is a...
|
|
WO/1995/033379A2 |
The efficacy of an agricultural chemical can be enhanced by using an enhancer for agricultural chemicals represented by formulas (I) or (II) together with the agricultural chemical. The enhancer for agricultural chemicals according to th...
|
|
WO/1995/029148A1 |
The invention concerns O-acyl-4-phenyl-cyclohexanols of the general formula (I) in which n stands for the numbers 0 or 1, m stands for the numbers 1 or 2, p stands for the numbers 0 or 1, R1 and R2 each stand for hydrogen, lower alkyl, a...
|
|
WO/1995/025713A1 |
Esterquats based on natural fats and oils can be directly produced by subjecting fatty acid glycerine ester to ester interchange, in the presence of alkaline and/or alkaline earth boron hydrides and hypophosphoric acid or their alkaline ...
|
|
WO/1995/023787A1 |
An industrially advantageous process for producing 5,7-dichloro-4-hydroxyquinoline (DCHQ) useful as an intermediate for agrohorticultural bactericides. The process comprises hydrolyzing 3-cyano- or 3-ethoxycarbonyl-5,7-dichloro-4-hydroxy...
|
|
WO/1995/023128A1 |
Diesters of carbonic acid disubstituted with primary, secondary or tertiary amine groups, pharmaceutically acceptable salts thereof, and their use as antiviral and anti-inflammatory agents.
|
|
WO/1995/021811A1 |
A novel benzylaminoethoxybenzene derivative represented by general formula (I), a salt thereof, or a solvate thereof; wherein R1 represents hydrogen, lower alkyl, lower hydroxyalkyl, lower alkoxyalkyl, aryl or benzyl; R2 represents hydro...
|
|
WO/1995/021175A1 |
This invention provides a compound having the formula R1-Y1-CHZ1-CH(NY2Y3)-CH2-Z2, wherein: R1 is a straight-chained alkyl, alkenyl or alkynyl group having from 8 to 19 carbon atoms in the aliphatic chain; Y1 is -CH=CH-, -C||C- or -CH(OH...
|
|
WO/1995/021150A1 |
Diquaternary ammonium esters useful as bleach activators are disclosed, as are bleach compositions comprising such an ester and a peroxygen compound which yields peroxide in solution.
|
|
WO/1995/021209A1 |
Amides and ethers of perfluoropolyoxyalkylene sulphonic- or perfluoropolyoxyalkylene carboxylic acids of general formula (I): RFR1FZQ wherein: RF represents CF3O-, C2F5O-, C3F7O-, C8F17O-, R1F represents (a), -(CF2CF2O)nCF2, -(CF2CF2CF2O...
|
|
WO/1995/020566A1 |
Proposed is an improved method for the reduction of the residual content of free alkylation agent in aqueous solutions of nitrogen-containing surfactants, the method calling for solutions of cationic, amphoteric and/or zwitterionic surfa...
|
|
WO/1995/020639A1 |
Described are aqueous solutions of esterquats which can be made more viscous by the addition of 0.1 to 2.0 % by wt., relative to the solutions, of sterols and/or sterol derivatives.
|
|
WO/1995/020568A1 |
Salicylates of esterifiable 'beta'-blockers, especially Atenolol-O-Aspirinate, Metoprolol-O-Aspirinate, Pindolol-O-Aspirinate and processes for their preparation are described.
|
|
WO/1995/019416A1 |
Aqueous solutions of quaternary fatty acid triethanolamine ester salts may be advantageously and permanently thickened by admixture of 0.01 to 0.1 % by weight (in relation to the solution) of possibly alkoxylated esters of fatty acids wi...
|
|
WO/1995/014654A1 |
Solid quaternary esters with improved emulsifying power in water are produced using per se known methods with alkylating agents to quaternize fatty acid triethanolamine esters of formula (I) in which R1CO is a saturated and/or unsaturate...
|
|
WO/1995/011221A1 |
The present invention features molecules with general structure (I) or (II) which can modulate on or activities of an inorganic ion receptor. Preferably, the molecule can mimic or block the effect of extracellular Ca2+ on a calcium recep...
|
|
WO/1995/010501A1 |
Allylaminoesters of formula (I) wherein R1 is H or lower alkyl, R2 is lower alkyl, lower phenylcycloalkyl or cycloalkyl, pyridyl or phenyl, lower phenylalkyl, lower diphenylalkyl, lower phenylalkenyl, in which the phenyl cycle is optiona...
|
|
WO/1995/010500A1 |
Quaternary fatty acid triethanol amine ester salts of formula (I) in which R1CO consists to the extent of 40 to 60 wt % of a linear acyl radical with 6 to 22 carbon atoms and 60 to 40 wt % of a branched acyl radical with 6 to 22 carbon a...
|
|
WO/1995/009590A1 |
Biodegradable absorption enhancers, especially useful in pharmaceutical formulations are compounds comprising a novel group of esters of long chain aliphatic acids with N,N-disubstituted amino alcohols. For example, the penetration promo...
|
|
WO/1995/008976A1 |
The present invention relates to compositions comprising a compound containing a nitrogen linked by an ester bond to an active substance radical having an efficient deposition of the active substance radical to a surface followed by dela...
|
|
WO/1995/008544A1 |
Aminocyclohexylester compounds, including thioesters, are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses a variety of in vitro and in vivo uses for the...
|
|
WO/1995/005180A1 |
Methods and pharmaceutical compositions effective to increase intracellular and plasma uridine concentrations are disclosed. Certain compositions and methods of using such compositions have been found to be effective to inhibit uridine s...
|
|
WO/1995/004532A1 |
Optically active or racemic compounds represented by formula (I) wherein R1, R2, R3, R5 and n are defined as in the specification, and pharmaceutically acceptable salts thereof. These compounds are useful for alleviating Parkinsonism, gl...
|
|
WO/1995/004713A1 |
Compounds and their pharmaceutically acceptable salts suitable for treating central nervous system disorders associated with the dopamine D3 receptor activity of formula (I), wherein R1 and R2 are independently chosen from hydrogen, C1-C...
|
|
WO/1995/000131A1 |
The invention relates to methods for the treatment of central nervous system disorders, neurological disorders, gastrointestinal disorders, drug abuse, angina, migraine, hypertension and depression by administering a pharmaceutical compo...
|
|
WO/1994/025665A1 |
A process for dyeing or printing organic material, preferably fibre material, which comprises applying dyes together with a colourless cationic compound containing at least two polymerisable double bonds, as well as additional optional a...
|
|
WO/1994/021595A1 |
An amine derivative of following general formula (I) or (II) (wherein R1 represents a heteroatom-containing C1-C40 hydrocarbon group which may have a ring structure, etc.; R2 to R6 each represent a C1-C10 hydrocarbon group, hydrogen, etc...
|
|
WO/1994/021597A1 |
An aniline derivative represented by chemical formula (I); and a process for producing 5-amino-2-chloro-4-fluorophenyl ethyl carbonate by reducing 2-chloro-4-fluoro-5-nitrophenyl ethyl carbonate.
|
|
WO/1994/021248A1 |
The invention pertains to the use of compounds of formula (I) wherein R1 and R2 stand for the constituents indicated in the description, and of their pharmacologically tolerable salts in the preparation of medicines for the treatment of ...
|
|
WO/1994/021593A1 |
Solid quaternary esters with improved dispersibility in water are obtained in that fatty acid triethanolamine esters, in the presence of a) dispersion agents, selected from the group of fatty alcohols, fatty acid monoglycerides and dialk...
|
|
WO/1994/021592A1 |
Solid quaternary esters with improved emulsifying power in water are obtained in that fatty acid triethanolamine esters of formula (I), in which R1CO is a saturated and/or unsaturated acyl group with 6-22 carbon atoms, R2 and R3 are, ind...
|
|
WO/1994/021596A1 |
The invention concerns quaternary fatty-acid triethanolamine ester salts of formula (I) in which R1CO is an acyl group with 6 to 22 carbon atoms; R2 and R3, independently of each other, are hydrogen or R1CO; R4 is an alkyl group with 1 t...
|
|
WO/1994/015011A1 |
Described are quaternary fatty-acid triethanolamine ester salts of formula (I) in which R1CO is an acyl group with 6 to 22 carbon atoms; R2 and R3, independently of each other, are hydrogen or R1CO; R4 is an alkyl group with 2 to 10 carb...
|
|
WO/1994/014754A1 |
An anilinium salt compound represented by general formula (I) and a cationic polymerization initiator containing at least one said compound, wherein R1 represents hydrogen, alkyl, etc.; R2 represents alkyl, etc.; R3 represents alkyl subs...
|
|
WO/1994/014756A1 |
Described are quaternary fatty-acid triethanolamine ester salts of formula (I) in which R1CO is an acyl group with 6 to 22 carbon atoms; R2 and R3, independently of each other, are hydrogen or R1CO; n is a number from 1 to 10; x, y and z...
|
|
WO/1994/012461A1 |
This invention relates to 4-substituted catechol diether compounds which are selective inhibitors of phosphodiesterase (PDE) type IV. The compounds of the present invention are useful in inhibiting PDEIV and in the treatment of AIDS, ast...
|
|
WO/1994/011405A1 |
The present invention is directed to novel propoxyphene derivatives which are synthesized for the covalent attachment to antigens (proteins or polypeptides) for the preparation of antibodies or receptors to propoxyphene and propoxyphene ...
|
|
WO/1994/008945A1 |
The invention concerns compounds of the formula (I): Ar1-CH(OH)-CH2-NH-CH2-X-CH2-E-(CH2)n-Y-Ar2, in which the substituents and the symbols are as defined in the description. Such compounds are active substances with, in particular, a bro...
|
|
WO/1994/008943A1 |
A 2-amino-1,3-propanediol compound represented by general formula (I) or a pharmaceutically acceptable salt thereof, and an immunosuppressant containing the same as the active ingredient. In said formula R represents optionally substitut...
|
|
WO/1994/007842A1 |
Compounds of formula (I) are useful as addivitives in oleaginous compositions, wherein B represents an aromatic system, A represents a hydrocarbyl group, R1 and R2 are the same or are different and each independently is an aliphatic hydr...
|
|
WO/1994/005624A1 |
The present invention discloses cationic lipids useful for making lipid aggregates for delivery of macromolecules and other compounds into cells. They are especially useful for the DNA-dependent transformation of cells. Also disclosed ar...
|
|
WO/1993/024445A1 |
Para-substitued benzyl amines of general formula (I) in which W is a carbonyl group or a single bond, R?1¿ is a lower alkyl group, R?2¿ is an alkyl radical with 5 to 20 carbon atoms which may be branched and contain 1 to 3 double bonds...
|
|
WO/1993/023364A1 |
Novel 2,5 dihydroxybenzylamine derivatives of general formula (I), their preparation and pharmaceutical compositions containing same. In general formula (I), one of the symbols R1 or R2 denots a hydrogen or halo atom or a hydroxy, alkoxy...
|
|
WO/1993/023357A1 |
The present invention relates to stilbene derivatives which possess utility as anti-cancer agents. The compounds can be used to treat cancers which are susceptible to treatment therewith, and can be utilized in a method of treating such ...
|
|
WO/1993/021383A1 |
Tissue paper webs useful in the manufacture of soft, absorbent products such as napkins, facial tissues, and sanitary tissues, and processes for making the webs. The tissue paper webs comprise papermaking fibers, a biodegradable quaterni...
|
|
WO/1993/021382A1 |
Tissue paper webs useful in the manufacture of soft, absorbent products such as paper towels, napkins, and facial tissues, and processes for making the webs. The tissue paper webs comprise papermaking fibers, a biodegradable quaternized ...
|
|
WO/1993/020044A1 |
Compounds of general formula (II) wherein R3 is C1-35 hydrocarbyl group optionally substituted by one to five substituents, selected from halo, C1-6alkoxy, hydroxy, amino, and mono- or di-C1-4alkyl-amino; and either the dotted line repre...
|
